Humana Cuts Earnings Outlook As Medical Costs Surge

Dow Jones
Nov 05
 

By Nicholas G. Miller

 

Humana reported lower third-quarter profit and slashed full-year earnings guidance as medical costs continue to surge, dragging down margins for the company's core Medicare Advantage business.

The health-insurance company on Wednesday reported net income of $1.62 a share, down from $3.98 a share the year prior.

Adjusted earnings were $3.24 a share. Analysts expected $2.93.

Revenue rose to $32.65 billion from $29.4 billion. Wall Street expected $32 billion.

The company's benefit ratio, which measures the proportion of premiums paid to cover medical costs, rose to 91.1% from 89.9% a year earlier.

Humana lowered its full-year earnings forecast to $12.26 a share, down from its previous guidance of $13.77 a share. It reiterated its adjusted-earnings outlook of $17 a share.

Analysts see earnings of $14.09 a share and adjusted earnings of $17.07 a share.

The Louisville, Ky., company said it now expects a decline of about 425,000 Medicare Advantage members for the year, up from its previous forecast of a decline of up to 500,000 members.

 

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

 

(END) Dow Jones Newswires

November 05, 2025 06:22 ET (11:22 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10